The risk of blood clots associated with AstraZeneca’s coronavirus vaccine is “very small,” the British Medicines Agency (MHRA) said on Friday.
The statement was made after the Thursday audit stated that they had registered 30 cases of the rare blood clot type among the 18 million AstraZeneca doses that have been administered.
“Based on this ongoing investigation, the benefits of the vaccine as protection against COVID-19 continue to outweigh any risks,” the MHRA noted.
The Authority added that they continue to ask people to accept the AstraZeneca vaccine.
A total of 31 million people have now been vaccinated against the coronavirus in the UK.
The number of new cases has recently dropped considerably and amounts to 55 cases per 100,000 inhabitants for the last seven days.
Source: © NTB Scanpix / #Norway Today / #NorwayTodayNews
Do you have a news tip for Norway Today? We want to hear it. Get in touch at email@example.com